Automating Literature to Evidence
01 Mar 2025
Transform weeks of complex medical literature work into minutes with AI-powered evidence generation.

Challenge
In the pharmaceutical industry, medical affairs teams are responsible for creating high-quality, evidence-based documents that demonstrate the safety and efficacy of new treatments. This requires time-intensive tasks such as:
Conducting literature database searches
Screening abstracts for relevance
Extracting metadata (authors, journals, dates)
Summarizing and structuring scientific findings
Ensuring every claim is correctly referenced
Creating a single coherent narrative from fragmented sources could take several days of manual work, especially when tailoring the content to diverse audiences, from clinicians and researchers to patients and stakeholders.
Solution
Common Sense AI developed a generative AI solution to automate the end-to-end workflow of evidence generation for medical affairs teams.
Built on large language model (LLM) technology, the solution supports:
Automated generation of search terms for literature databases
Abstract screening and filtering for relevance
Metadata extraction from publications
Drafting of scientifically accurate, well-structured content
On-demand answers to targeted medical questions, with references
By integrating domain-specific knowledge into the AI pipeline, the tool transforms raw literature inputs into a polished, readable, and referenced draft, ready for review and final editing.
Result
The impact was substantial:
Time savings: what previously took several days was now achievable in minutes
Greater consistency in scientific writing and referencing
More strategic focus for medical teams, shifting effort from manual processing to high-value analysis
Improved responsiveness, with on-demand generation of summaries, comparisons, and claims across therapeutic areas
This project shows how generative AI can transform medical content creation, accelerating workflows, increasing accuracy, and supporting faster, more informed communication across the pharmaceutical sector.